These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32022782)

  • 1. Experiences of BRCA1/2 Gene Mutation-Positive Women With Cancer in Communicating Genetic Risk to Their Relatives.
    Seven M; Shah LL; Daack-Hirsch S; Yazici H
    Cancer Nurs; 2021 May-Jun 01; 44(3):E142-E150. PubMed ID: 32022782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
    Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
    Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
    J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
    Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
    Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives.
    Skasko E; Paszko Z; Niwińska A; Kwiatkowska E; Kruczek A; Pieńkowski T
    Eur J Gynaecol Oncol; 2004; 25(4):470-4. PubMed ID: 15285306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Probands to Relatives: Communication of Genetic Risk for Hereditary Breast-Ovarian Cancer and Its Influence on Subsequent Testing.
    Seven M; Shah LL; Yazici H; Daack-Hirsch S
    Cancer Nurs; 2022 Jan-Feb 01; 45(1):E91-E98. PubMed ID: 32804756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
    Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
    Am J Med Genet A; 2003 Jan; 116A(1):11-9. PubMed ID: 12476445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communication of BRCA results and family testing in 1,103 high-risk women.
    Cheung EL; Olson AD; Yu TM; Han PZ; Beattie MS
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2211-9. PubMed ID: 20699375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Communicating BRCA1/2 genetic test results within the family: a qualitative analysis.
    Dancyger C; Wiseman M; Jacobs C; Smith JA; Wallace M; Michie S
    Psychol Health; 2011 Aug; 26(8):1018-35. PubMed ID: 21797732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.
    Ratnayake P; Wakefield CE; Meiser B; Suthers G; Price MA; Duffy J; ; Tucker K
    Fam Cancer; 2011 Mar; 10(1):97-105. PubMed ID: 20878485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.
    Sanz J; Ramón y Cajal T; Torres A; Darder E; Gadea N; Velasco A; Fortuny D; López C; Fisas D; Brunet J; Alonso MC; Balmaña J
    Fam Cancer; 2010 Sep; 9(3):297-304. PubMed ID: 20091130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting.
    Lee DS; Meiser B; Mariapun S; Hassan T; Yip CH; Mohd Taib NA; Teo SH; Thong MK; Yoon SY
    J Genet Couns; 2021 Jun; 30(3):720-729. PubMed ID: 33245177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results.
    Hughes C; Lerman C; Schwartz M; Peshkin BN; Wenzel L; Narod S; Corio C; Tercyak KP; Hanna D; Isaacs C; Main D
    Am J Med Genet; 2002 Jan; 107(2):143-50. PubMed ID: 11807889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.
    Montgomery SV; Barsevick AM; Egleston BL; Bingler R; Ruth K; Miller SM; Malick J; Cescon TP; Daly MB
    Fam Cancer; 2013 Sep; 12(3):537-46. PubMed ID: 23420550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
    Finlay E; Stopfer JE; Burlingame E; Evans KG; Nathanson KL; Weber BL; Armstrong K; Rebbeck TR; Domchek SM
    Genet Test; 2008 Mar; 12(1):81-91. PubMed ID: 18373407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
    Nippert I; Schlegelberger B;
    Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.
    Dorval M; Patenaude AF; Schneider KA; Kieffer SA; DiGianni L; Kalkbrenner KJ; Bromberg JI; Basili LA; Calzone K; Stopfer J; Weber BL; Garber JE
    J Clin Oncol; 2000 May; 18(10):2135-42. PubMed ID: 10811679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
    Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.
    Jeffers L; Morrison PJ; McCaughan E; Fitzsimons D
    Eur J Oncol Nurs; 2014 Aug; 18(4):411-8. PubMed ID: 24731853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.